We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBT
2951
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$145K ﹤0.01%
+15,052
New +$136K
KT icon
2952
KT
KT
$8.81B
$143K ﹤0.01%
+10,490
New +$149K
NAB
2953
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
$143K ﹤0.01%
+14,348
New +$143K
CRD.A icon
2954
Crawford & Co Class A
CRD.A
$669M
$141K ﹤0.01%
15,744
+91
+0.6% +$892
PBFS icon
2955
Pioneer Bancorp
PBFS
$434M
$139K ﹤0.01%
10,990
-108
-1% -$1.3K
WIT icon
2956
Wipro
WIT
$20B
$139K ﹤0.01%
+31,544
New +$138K
HOFV
2957
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$138K ﹤0.01%
2,359
+70
+3% +$4.69K
IMUX icon
2958
Immunic
IMUX
$195M
$136K ﹤0.01%
1,532
+116
+8% +$11.4K
SEEL
2959
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$134K ﹤0.01%
14
VIA
2960
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$133K ﹤0.01%
2,610
-115
-4% -$6.38K
MILE
2961
DELISTED
Metromile, Inc. Common Stock
MILE
$133K ﹤0.01%
37,349
+1,725
+5% +$9.73K
OYST
2962
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$132K ﹤0.01%
11,176
+525
+5% +$7.65K
MXCT icon
2963
MaxCyte
MXCT
$126M
$131K ﹤0.01%
+10,737
New +$162K
ARDX icon
2964
Ardelyx
ARDX
$997M
$129K ﹤0.01%
97,565
+3,390
+4% +$9.05K
FLNT
2965
Fluent
FLNT
$120M
$128K ﹤0.01%
9,369
-154
-2% -$2.31K
KLTR icon
2966
Kaltura
KLTR
$267M
$128K ﹤0.01%
+12,397
New +$146K
STIM icon
2967
Neuronetics
STIM
$166M
$126K ﹤0.01%
19,282
+1,479
+8% +$14.2K
EAR
2968
DELISTED
Eargo, Inc. Common Stock
EAR
$123K ﹤0.01%
913
+44
+5% +$23.5K
TISI icon
2969
Team
TISI
$77.7M
$122K ﹤0.01%
4,040
-6,116
-60% -$295K
ATCX
2970
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$122K ﹤0.01%
11,994
+697
+6% +$7.2K
CLPR
2971
Clipper Realty
CLPR
$46.2M
$119K ﹤0.01%
14,720
-1,293
-8% -$10.5K
STKS icon
2972
The ONE Group
STKS
$53M
$119K ﹤0.01%
11,105
+890
+9% +$9.18K
HARP
2973
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$118K ﹤0.01%
1,496
+40
+3% +$4.02K
FTCI icon
2974
FTC Solar
FTCI
$44.9M
$117K ﹤0.01%
1,507
+75
+5% +$7.58K
FORA
2975
DELISTED
Forian
FORA
$116K ﹤0.01%
11,193
+935
+9% +$10.4K

Similar funds

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.